Financials

  • Market Capitalization 8.4 B
  • Employee 399
  • Founded 1993
  • CEO Michael S Weiss
  • Website www.tgtherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000FVZQY1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
10.76
市销率
7.81

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
999
SYRE
Spyre Therapeutics, Inc. - Common Stock
98.95 USD+5.57%+4.89%+18.45%+313.84%8.59 B USD
1006
PTGX
Protagonist Therapeutics, Inc. - Common Stock
131.27 USD+1.06%-5.90%+16.34%+74.72%8.44 B USD
1017
APGE
Apogee Therapeutics, Inc. - Common Stock
133.96 USD+0.10%+0.33%+55.42%+149.97%8.29 B USD
1022
IBRX
ImmunityBio, Inc. - Common Stock
7.88 USD+1.16%-9.43%+10.67%+184.48%8.25 B USD

新闻